The Tumor Necrosis Factor (TNF) Inhibitor Drugs Market on a global scale had a total worth of $42.22 billion in the year 2022, and it is anticipated to reach a value of $60.09 billion by the year 2032. Over the forecast period, the market is expected to achieve a compound annual growth rate (CAGR) of 4% in terms of revenue. This growth can be attributed to several factors, including the...